{
    "nctId": "NCT02247128",
    "officialTitle": "Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation",
    "inclusionCriteria": "* Cohort A\n\n  1. Patient has provided written informed consent.\n* Cohort B\n\n  1. Need for long-term oral anticoagulation;\n  2. Patient has provided written informed consent.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Cohort A\n\n  1. Need for long-term oral anticoagulation;\n  2. Drug-eluting stent implantation within 3 months prior to TAVI procedure;\n  3. Bare-metal stent implantation within 1 month prior to TAVI procedure;\n  4. Allergy or intolerance to aspirin or clopidogrel.\n* Cohort B\n\n  1. Drug-eluting stent implantation within 3 months prior to TAVI procedure;\n  2. Bare-metal stent implantation within 1 month prior to TAVI procedure;\n  3. Allergy or intolerance to (N)OAC or clopidogrel."
}